149 related articles for article (PubMed ID: 34059347)
1. Histologic evaluation of host immune microenvironment and its prognostic significance in oral tongue squamous cell carcinoma: a comparative study on lymphocytic host response (LHR) and tumor infiltrating lymphocytes (TILs).
Xu B; Salama AM; Valero C; Yuan A; Khimraj A; Saliba M; Zanoni DK; Ganly I; Ghossein R; Patel SG; Katabi N
Pathol Res Pract; 2021 Dec; 228():153473. PubMed ID: 34059347
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.
Chatzopoulos K; Sotiriou S; Collins AR; Kartsidis P; Schmitt AC; Chen X; Khazaie K; Hinni ML; Ramsower CA; Zarka MA; Patel SH; Garcia JJ
Head Neck Pathol; 2021 Jun; 15(2):509-522. PubMed ID: 33010009
[TBL] [Abstract][Full Text] [Related]
3. The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
Troiano G; Rubini C; Togni L; Caponio VCA; Zhurakivska K; Santarelli A; Cirillo N; Lo Muzio L; Mascitti M
Cancer Med; 2020 Nov; 9(22):8333-8344. PubMed ID: 33047888
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer.
Heikkinen I; Bello IO; Wahab A; Hagström J; Haglund C; Coletta RD; Nieminen P; Mäkitie AA; Salo T; Leivo I; Almangush A
Am J Surg Pathol; 2019 Oct; 43(10):1392-1396. PubMed ID: 31290758
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of histologic grade, worst pattern of invasion, and tumor budding in early oral tongue squamous cell carcinoma: a comparative study.
Xu B; Salama AM; Valero C; Yuan A; Khimraj A; Saliba M; Zanoni DK; Ganly I; Patel SG; Katabi N; Ghossein R
Virchows Arch; 2021 Sep; 479(3):597-606. PubMed ID: 33661329
[TBL] [Abstract][Full Text] [Related]
7. Stromal categorization in early oral tongue cancer.
Almangush A; Bello IO; Heikkinen I; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
Virchows Arch; 2021 May; 478(5):925-932. PubMed ID: 32955604
[TBL] [Abstract][Full Text] [Related]
8. Evaluation Challenges in the Validation of B7-H3 as Oral Tongue Cancer Prognosticator.
Sieviläinen M; Wirsing AM; Hyytiäinen A; Almahmoudi R; Rodrigues P; Bjerkli IH; Åström P; Toppila-Salmi S; Paavonen T; Coletta RD; Hadler-Olsen E; Salo T; Al-Samadi A
Head Neck Pathol; 2021 Jun; 15(2):469-478. PubMed ID: 32959211
[TBL] [Abstract][Full Text] [Related]
9. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue.
Gu X; Boldrup L; Coates PJ; Fahraeus R; Wang L; Wilms T; Norberg-Spaak L; Sgaramella N; Nylander K
J Pathol Clin Res; 2019 Oct; 5(4):240-247. PubMed ID: 31237113
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence.
Naruse T; Yanamoto S; Okuyama K; Ohmori K; Tsuchihashi H; Furukawa K; Yamada SI; Umeda M
Pathol Oncol Res; 2020 Apr; 26(2):735-742. PubMed ID: 30767115
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
[TBL] [Abstract][Full Text] [Related]
12. A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer.
Bjerkli IH; Hadler-Olsen E; Nginamau ES; Laurvik H; Søland TM; Costea DE; Uhlin-Hansen L; Steigen SE
Virchows Arch; 2020 Dec; 477(6):865-872. PubMed ID: 32607687
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
[TBL] [Abstract][Full Text] [Related]
14. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
[TBL] [Abstract][Full Text] [Related]
15. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating CD1a
Ni YH; Zhang XX; Lu ZY; Huang XF; Wang ZY; Yang Y; Dong YC; Jing Y; Song Y; Hou YY; Hua ZC; Hu QG
Pathol Oncol Res; 2020 Jul; 26(3):1687-1695. PubMed ID: 31606786
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor budding thresholds in oral tongue squamous cell carcinoma.
Mascitti M; Togni L; Caponio VCA; Zhurakivska K; Lo Muzio L; Rubini C; Santarelli A; Troiano G
Oral Dis; 2023 Jul; 29(5):1947-1958. PubMed ID: 35316866
[TBL] [Abstract][Full Text] [Related]
19. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C
BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
